A. A. Lyakishev

475 total citations
22 papers, 373 citations indexed

About

A. A. Lyakishev is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Immunology. According to data from OpenAlex, A. A. Lyakishev has authored 22 papers receiving a total of 373 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 8 papers in Cardiology and Cardiovascular Medicine and 5 papers in Immunology. Recurrent topics in A. A. Lyakishev's work include Lipoproteins and Cardiovascular Health (10 papers), Atherosclerosis and Cardiovascular Diseases (5 papers) and Adipokines, Inflammation, and Metabolic Diseases (4 papers). A. A. Lyakishev is often cited by papers focused on Lipoproteins and Cardiovascular Health (10 papers), Atherosclerosis and Cardiovascular Diseases (5 papers) and Adipokines, Inflammation, and Metabolic Diseases (4 papers). A. A. Lyakishev collaborates with scholars based in Russia. A. A. Lyakishev's co-authors include Alexander N. Orekhov, V.V. Tertov, Vladimir N. Smirnov, Bernard Lown, Philip J. Podrid, I. Adamová, S. Pokrovsky, Tkachuk Va, Perova Nv and Sergey Kozlov and has published in prestigious journals such as The Lancet, Circulation and Circulation Research.

In The Last Decade

A. A. Lyakishev

20 papers receiving 348 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. A. Lyakishev Russia 10 154 126 116 71 46 22 373
T. Royo Spain 13 162 1.1× 86 0.7× 106 0.9× 122 1.7× 62 1.3× 24 474
Marc-André Lavoie Canada 9 193 1.3× 77 0.6× 61 0.5× 92 1.3× 42 0.9× 12 385
Lillemor Mattsson-Hultén Sweden 9 137 0.9× 88 0.7× 91 0.8× 121 1.7× 77 1.7× 12 372
Badimón Jj United States 6 241 1.6× 170 1.3× 55 0.5× 73 1.0× 33 0.7× 10 459
Tetsuya Totsuka Japan 10 187 1.2× 48 0.4× 94 0.8× 97 1.4× 24 0.5× 14 366
Hans P. Deigner Germany 8 117 0.8× 67 0.5× 94 0.8× 134 1.9× 84 1.8× 10 376
Jérôme Paysant France 15 82 0.5× 68 0.5× 127 1.1× 115 1.6× 58 1.3× 23 495
Yoshifumi Okura Japan 9 106 0.7× 67 0.5× 49 0.4× 117 1.6× 35 0.8× 22 336
Charles Solymoss Canada 5 294 1.9× 213 1.7× 55 0.5× 51 0.7× 34 0.7× 6 443

Countries citing papers authored by A. A. Lyakishev

Since Specialization
Citations

This map shows the geographic impact of A. A. Lyakishev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. A. Lyakishev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. A. Lyakishev more than expected).

Fields of papers citing papers by A. A. Lyakishev

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. A. Lyakishev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. A. Lyakishev. The network helps show where A. A. Lyakishev may publish in the future.

Co-authorship network of co-authors of A. A. Lyakishev

This figure shows the co-authorship network connecting the top 25 collaborators of A. A. Lyakishev. A scholar is included among the top collaborators of A. A. Lyakishev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. A. Lyakishev. A. A. Lyakishev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Parfyonova, Yelena, О. С. Плеханова, А. Д. Деев, et al.. (2013). Plasma urokinase antigen and C-reactive protein predict angina recurrence after coronary angioplasty. Heart and Vessels. 29(5). 611–618. 2 indexed citations
2.
Ежов, М. В., et al.. (2010). MS341 EFFECT OF NIACIN WITH ATORVASTATIN ON SECRETORY PHOSPHOLIPASE A2 IN MEN WITH CORONARY HEART DISEASE AND LIPOPROTEIN(a) EXCESS. Atherosclerosis Supplements. 11(2). 178–178. 1 indexed citations
3.
Safarova, Maya, М. В. Ежов, O. Afanasieva, A. A. Lyakishev, & S. Pokrovsky. (2010). P151 ASSOCIATION OF ELEVATED LIPOPROTEIN(a) LEVEL WITH PREMATURE CORONARY HEART DISEASE IN MEN AND WOMEN. Atherosclerosis Supplements. 11(2). 48–48. 1 indexed citations
4.
5.
6.
7.
Orekhov, Alexander N., et al.. (1995). Diagnostic Value of Immune Cholesterol as a Marker for Atherosclerosis. European Journal of Cardiovascular Prevention & Rehabilitation. 2(5). 459–466. 19 indexed citations
8.
Orekhov, Alexander N., et al.. (1995). Diagnostic value of immune cholesterol as a marker for atherosclerosis. Journal of Cardiovascular Risk. 2(5). 459???466–459???466. 9 indexed citations
9.
Lyakishev, A. A., et al.. (1995). Pharmacokinetics of probucol dosage forms in clinical tests. Pharmaceutical Chemistry Journal. 29(4). 245–247. 6 indexed citations
10.
Pokrovsky, S., et al.. (1994). Extracorporeal immunoadsorption for the specific removal of lipoprotein (a) (Lp(a) apheresis): preliminary clinical data. Chemistry and Physics of Lipids. 67-68. 323–330. 36 indexed citations
11.
Bochkov, Valery N., et al.. (1992). Platelets in patients with homozygous familial hypercholesterolemia are sensitive to Ca-mobilizing activity of low density lipoproteins. Atherosclerosis. 96(2-3). 119–124. 17 indexed citations
12.
Bochkov, Valery N., et al.. (1991). LDL- and agonist-induced Ca2+-mobilization in platelets of healthy subjects and in patients with familial hyperlipoproteinemia type II. Thrombosis Research. 61(4). 403–409. 10 indexed citations
13.
Orekhov, Alexander N., et al.. (1991). Use of cultured atherosclerotic cells for investigation of antiatherosclerotic effects of anipamil and other calcium antagonists.. PubMed. 5(5). 425–30. 4 indexed citations
14.
Tertov, Vladimir V., et al.. (1989). Peritoneal Macrophages: A Model for Detecting Atherogenic Potential in Patients' Blood Serum. Annals of Medicine. 21(6). 455–459. 5 indexed citations
15.
Orekhov, Alexander N., Vladimir V. Tertov, Khairulla A. Khashimov, et al.. (1988). Atherogenic effects of beta blockers on cells cultured from normal and atherosclerotic aorta. The American Journal of Cardiology. 61(13). 1116–1117. 9 indexed citations
16.
Orekhov, Alexander N., V.V. Tertov, S. Pokrovsky, et al.. (1988). Blood serum atherogenicity associated with coronary atherosclerosis. Evidence for nonlipid factor providing atherogenicity of low-density lipoproteins and an approach to its elimination.. Circulation Research. 62(3). 421–429. 56 indexed citations
17.
Orekhov, Alexander N., V.V. Tertov, Sergey Kozlov, et al.. (1988). Cardiovascular drugs and atherosclerosis: effects of calcium antagonists, beta-blockers, and nitrates on atherosclerotic characteristics of human aortic cells.. PubMed. 12 Suppl 6. S66–8. 32 indexed citations
18.
Orekhov, Alexander N., Vladimir V. Tertov, Sergey Kozlov, et al.. (1988). Cardiovascular Drugs and Atherosclerosis. Journal of Cardiovascular Pharmacology. 12(Supplement 6). S66–S68. 19 indexed citations
19.
Чазов, Е. И., Alexander N. Orekhov, Perova Nv, et al.. (1986). ATHEROGENICITY OF BLOOD SERUM FROM PATIENTS WITH CORONARY HEART DISEASE. The Lancet. 328(8507). 595–598. 57 indexed citations
20.
Podrid, Philip J., et al.. (1980). Ethmozin, a new antiarrhythmic drug for suppressing ventricular premature complexes.. Circulation. 61(2). 450–457. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by T. Royo Breakdown of academic impact, for papers by Marc-André Lavoie Breakdown of academic impact, for papers by Lillemor Mattsson-Hultén Breakdown of academic impact, for papers by Badimón Jj Breakdown of academic impact, for papers by Tetsuya Totsuka Breakdown of academic impact, for papers by Hans P. Deigner Breakdown of academic impact, for papers by Jérôme Paysant Breakdown of academic impact, for papers by Yoshifumi Okura Breakdown of academic impact, for papers by Charles Solymoss
Rankless by CCL
2026